Paris: Standing Ovation, a French precision fermentation pioneer producing next-generation proteins, has announced a $34.2 million (£30 million) Series B financing round, including $28.5 million in equity (£25 million). This round was co-led by the Ecotechnologies 2 fund, managed on behalf of the French government by Bpifrance as part of the France 2030 initiative, and Cr©dit Mutuel Innovation. The investment saw participation from existing investors such as Astanor, Bel Group, Seventure Partners, GoodStartUp, and Big Idea Ventures, and welcomed new investors including Danone Ventures, Angelor, Newtree, and Noshaq. The funding is further supported by $5.7 million (£5 million) in non-dilutive financing provided by Bpifrance and a leading banking syndicate.

According to BERNAMA News Agency, this new funding round, which follows a £16 million Series A, is set to finance the commercial rollout of Standing Ovation's proteins in the United States and, starting at the end of 2027, in Europe and Asia. The investment from French agri-food giants Groupe Bel and Danone endorses Standing Ovation's sustainable and sovereign model. Standing Ovation is revolutionizing dairy protein production with a patented process that converts whey permeates into high-value caseins, a premium ingredient in high demand across the global agrifood industry. The ability to repurpose dairy co-products, which currently have little to no value, marks a significant achievement that could reshape the future of the ecosystem.